Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
D W Miles, O Fogarty, C M Ash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial
R Glynne-Jones, L Kadalayil, H M Meadows, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2019
Combining conventional therapy with immunotherapy: A risky business?
A Coosemans, A Vankerckhoven, T Baert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2006
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
P Pedrazzoli, J A Ledermann, J-P Lotz, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Use of second antibody in radioimmunotherapy
R H Begent, K D Bagshawe, R B Pedley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2025
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial
G Eminowicz, S Vaja, D Gallardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2013
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data
F A Raja, N Counsell, N Colombo, et al.
Gynecologic Oncology
|
October 20, 2020
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer
M R Hall, H-M Dehbi, S Banerjee, et al.
British Journal of Cancer
|
September 1, 1994
Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies
D M Lane, K F Eagle, R H Begent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer
G Rustin, N Reed, G C Jayson, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
D W Miles, O Fogarty, C M Ash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial
R Glynne-Jones, L Kadalayil, H M Meadows, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2019
Combining conventional therapy with immunotherapy: A risky business?
A Coosemans, A Vankerckhoven, T Baert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2006
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
P Pedrazzoli, J A Ledermann, J-P Lotz, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Use of second antibody in radioimmunotherapy
R H Begent, K D Bagshawe, R B Pedley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2025
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial
G Eminowicz, S Vaja, D Gallardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2013
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data
F A Raja, N Counsell, N Colombo, et al.
Gynecologic Oncology
|
October 20, 2020
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer
M R Hall, H-M Dehbi, S Banerjee, et al.
British Journal of Cancer
|
September 1, 1994
Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies
D M Lane, K F Eagle, R H Begent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer
G Rustin, N Reed, G C Jayson, et al.
Page
of 7